Deutsche Bank Ag\ Alaunos Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.41 - $1.24 $49,802 - $150,621	-121,469 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.62 - $1.17 $8,377 - $15,809	-13,512 Reduced 10.01%	121,469 $79,000
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $7,345 - $12,736	6,739 Added 5.25%	134,981 $147,000
Q3 2021 Nov 04, 2021	SELL	$1.44 - $2.73 $33,426 - $63,371	-23,213 Reduced 15.33%	128,242 $233,000
Q2 2021 Aug 11, 2021	SELL	$2.63 - $3.67 $31,928 - $44,553	-12,140 Reduced 7.42%	151,455 $400,000
Q1 2021 May 13, 2021	SELL	$2.82 - $5.6 $421,547 - $837,116	-149,485 Reduced 47.75%	163,595 $588,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $42,059 - $62,183	20,124 Added 6.87%	313,080 $789,000
Q3 2020 Nov 12, 2020	BUY	$2.39 - $3.43 $16,297 - $23,389	6,819 Added 2.38%	292,956 $738,000
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $300,599 - $506,919	136,636 Added 91.39%	286,137 $938,000
Q1 2020 May 14, 2020	BUY	$1.9 - $4.98 $171,910 - $450,585	90,479 Added 153.3%	149,501 $367,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $109,020 - $147,660	-27,600 Reduced 31.86%	59,022 $277,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $143,765 - $241,581	34,810 Added 67.19%	86,622 $370,000
Q2 2019 Aug 14, 2019	SELL	$3.98 - $6.2 $9,862 - $15,363	-2,478 Reduced 4.56%	51,812 $299,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $35,002 - $77,004	-17,501 Reduced 24.38%	54,290 $208,000
Q4 2018 Feb 14, 2019	SELL	$1.61 - $3.62 $657,457 - $1.48 Million	-408,359 Reduced 85.05%	71,791 $133,000
Q3 2018 Dec 21, 2021	BUY	$2.26 - $3.27 $485,269 - $702,137	214,721 Added 80.9%	480,150 $1.54 Million
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $17,571 - $25,424	7,775 Added 3.02%	265,429 $848,000
Q2 2018 Apr 21, 2020	BUY	$3.02 - $4.94 $146,213 - $239,170	48,415 Added 23.14%	257,654 $778,000
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $1.29 Million - $2.11 Million	-426,505 Reduced 67.09%	209,239 $631,000
Q1 2018 Oct 18, 2019	BUY	$3.46 - $5.14 $898,136 - $1.33 Million	259,577 Added 69.01%	635,744 $2.49 Million
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $283,304 - $420,863	81,880 Added 27.82%	376,167 $1.47 Million
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $688,908 - $1.13 Million	172,227 Added 141.1%	294,287 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $609,079 - $801,934	122,060	122,060 $749,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $348M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account